Safety and Antiviral Study of ACH126, 433 (b-L-Fd4C) in Adults With Lamivudine-resistant Chronic Hepatitis B

NCT00040144 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
85
Enrollment
INDUSTRY
Sponsor class

Stopped Safety concerns

Conditions

Interventions

Sponsor

Alexion Pharmaceuticals, Inc.

Collaborators